
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3EPreprint%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="E0CA26CF930B3AD30026CF0008468DD0.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="biorxiv">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="preprint">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="bioRxiv">
<meta name="citation_title" content="Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation">
<meta name="citation_author" content="Yang Yu">
<meta name="citation_author_institution" content="Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.">
<meta name="citation_author" content="Austin Arrigo">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Ankush Chandra">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Chuling Zhuang">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Mariana K Najjar">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Munazza S Khan">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Dongqin Zhu">
<meta name="citation_author_institution" content="Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.">
<meta name="citation_author" content="Antonio Dono">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Roy E Strowd">
<meta name="citation_author_institution" content="Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC.">
<meta name="citation_author" content="Nitin Tandon">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Jay-Jiguang Zhu">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Sigmund H Hsu">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Yoshua Esquenazi">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author" content="Michael Chan">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC.">
<meta name="citation_author" content="Hui-Wen Lo">
<meta name="citation_author_institution" content="Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.">
<meta name="citation_author_institution" content="Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author_institution" content="The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.">
<meta name="citation_author_institution" content="Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA">
<meta name="citation_publication_date" content="2025 Feb 26">
<meta name="citation_firstpage" content="2025.02.20.639359">
<meta name="citation_doi" content="10.1101/2025.02.20.639359">
<meta name="citation_pmid" content="40060625">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/pdf/nihpp-2025.02.20.639359v1.pdf">
<meta name="description" content="Glioblastoma (GBM) remains the most aggressive primary brain tumor in adults, with no effective treatments. While cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) show clinical promise in some cancers, they have not significantly improved survival ...">
<meta name="og:title" content="Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Glioblastoma (GBM) remains the most aggressive primary brain tumor in adults, with no effective treatments. While cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) show clinical promise in some cancers, they have not significantly improved survival ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11888219">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1101/2025.02.20.639359"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/nihpp-2025.02.20.639359v1.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11888219%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11888219/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11888219/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <div class="usa-alert usa-alert--info" role="status"><div class="usa-alert__body">
<h4 class="usa-alert__heading">This is a preprint.</h4>
<p class="usa-alert__text"><strong>It has not yet been peer reviewed by a journal.</strong></p>
<p class="usa-alert__text">The National Library of Medicine is <a href="/about/nihpreprints/" class="usa-link">running a pilot</a> to include preprints that result from research funded by NIH in PMC and PubMed.</p>
</div></div><section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-preprints.png" alt="bioRxiv logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to bioRxiv" title="Link to bioRxiv" shape="default" href="https://pmc.ncbi.nlm.nih.gov/about/nihpreprints/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">bioRxiv</button></div> [Preprint]. 2025 Feb 26:2025.02.20.639359. [Version 1] doi: <a href="https://doi.org/10.1101/2025.02.20.639359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1101/2025.02.20.639359</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22bioRxiv%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22bioRxiv%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22bioRxiv%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22bioRxiv%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yang Yu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yang Yu</span></h3>
<div class="p">
<sup>1</sup>Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Yu</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arrigo%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Austin Arrigo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Austin Arrigo</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arrigo%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Austin Arrigo</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandra%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ankush Chandra</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ankush Chandra</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandra%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ankush Chandra</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhuang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Chuling Zhuang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Chuling Zhuang</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">
<sup>3</sup>The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhuang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chuling Zhuang</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Najjar%20MK%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mariana K Najjar</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mariana K Najjar</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">
<sup>3</sup>The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Najjar%20MK%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariana K Najjar</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20MS%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Munazza S Khan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Munazza S Khan</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">
<sup>3</sup>The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20MS%22%5BAuthor%5D" class="usa-link"><span class="name western">Munazza S Khan</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Dongqin Zhu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Dongqin Zhu</span></h3>
<div class="p">
<sup>1</sup>Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dongqin Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dono%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Antonio Dono</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Antonio Dono</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dono%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Antonio Dono</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Strowd%20RE%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Roy E Strowd</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Roy E Strowd</span></h3>
<div class="p">
<sup>4</sup>Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Strowd%20RE%22%5BAuthor%5D" class="usa-link"><span class="name western">Roy E Strowd</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tandon%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Nitin Tandon</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Nitin Tandon</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tandon%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nitin Tandon</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20JJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Jay-Jiguang Zhu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Jay-Jiguang Zhu</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20JJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Jay-Jiguang Zhu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsu%20SH%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Sigmund H Hsu</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Sigmund H Hsu</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsu%20SH%22%5BAuthor%5D" class="usa-link"><span class="name western">Sigmund H Hsu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Esquenazi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Yoshua Esquenazi</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Yoshua Esquenazi</span></h3>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Esquenazi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yoshua Esquenazi</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chan%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Michael Chan</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Michael Chan</span></h3>
<div class="p">
<sup>5</sup>Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chan%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael Chan</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo%20HW%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Hui-Wen Lo</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Hui-Wen Lo</span></h3>
<div class="p">
<sup>1</sup>Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.</div>
<div class="p">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">
<sup>3</sup>The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div class="p">
<sup>6</sup>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo%20HW%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui-Wen Lo</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>6,</sup><sup>#</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>1</sup>Department of Cancer Biology, Wake Forest School University of Medicine, Winston-Salem, NC.</div>
<div id="A2">
<sup>2</sup>Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div id="A3">
<sup>3</sup>The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</div>
<div id="A4">
<sup>4</sup>Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC.</div>
<div id="A5">
<sup>5</sup>Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC.</div>
<div id="A6">
<sup>6</sup>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA</div>
<div class="author-notes p">
<div class="fn" id="FN1">
<sup>*</sup><p class="display-inline" id="P1">Co-first authors with equal contribution</p>
</div>
<div class="fn" id="FN2">
<p id="P2">Authors Contributions</p>
<p id="P3">Conceptualization: Y.Y. and H.W.L. Original draft writing, preparation of figures and tables: Y.Y., A.A., A.C. (co-first authorship). Data acquisition and analysis: Y.Y., A.A., A.C., M.C., D.Z., A.D.O. Revising and editing: A.C., C.Z., M.K.N., M.S.K., D.Z, A.D.O., Y.E., N.T., J.J.Z., S.H.H., R.E.S., M.C., H.W.L. Supervision; H.W.L. All authors have read and agreed to the published version of the manuscript.</p>
</div>
<div class="fn" id="CR1">
<sup>#</sup><p class="display-inline">Correspondence: Hui-Wen Lo, Ph.D., MSE R162, 6431 Fannin Street, Houston, TX 77030, <span>Hui-Wen.Lo@uth.tmc.edu</span></p>
</div>
</div>
</div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This work is licensed under a <a href="https://creativecommons.org/licenses/by-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-NoDerivatives 4.0 International License</a>, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11888219Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40060625/" class="usa-link">40060625</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>The complete version history of this preprint is available at <a href="https://doi.org/10.1101/2025.02.20.639359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">bioRxiv</a>.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ABS1"><h2>Abstract</h2>
<p id="P4">Glioblastoma (GBM) remains the most aggressive primary brain tumor in adults, with no effective treatments. While cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) show clinical promise in some cancers, they have not significantly improved survival in GBM patients. This lack of response is attributed to the treatment-resistant glioma stem cell (GSC) population. We previously identified truncated glioma-associated oncogene homolog 1 (tGLI1) as a novel transcription factor promoting GSCs; however, its role in CDK4/6i resistance has never been investigated in any cancer type. Here, we found positive correlations between tGLI1 and CDK4/6 therapeutic resistance in patient datasets and <em>in vitro</em> studies. Pharmacological inhibition of tGLI1 using FDA-approved ketoconazole (KCZ), a tGLI1-specific inhibitor, sensitized GBM and GSCs to CDK4/6is. KCZ+CDK4/6i combination therapy demonstrated synergistic anti-proliferative effects, significantly inhibiting GBM stemness and cell cycle progression while increasing apoptosis. The combination was more efficacious than monotherapies in two orthotopic GBM mouse models. tGLI1 promoted GBM resistance to radiation therapy and temozolomide, while KCZ potentiated effects of these treatments. Collectively, we report for the first time that tGLI1 is a novel mediator of GBM resistance to CDK4/6is, and KCZ sensitizes GBM to CDK4/6is, thereby supporting future clinical utility of novel KCZ+CDK4/6i combinatorial therapy for GBM patients.</p></section><section id="S1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="P5">Glioblastoma (GBM) is the most common primary malignant brain tumor diagnosed in adults, comprising about half of all malignant brain tumors (<a href="#R1" class="usa-link" aria-describedby="R1">1</a>, <a href="#R2" class="usa-link" aria-describedby="R2">2</a>). Despite advancements in tumor biology and novel therapies, the standard-of-care therapy for GBM patients remains maximal safe tumor resection followed by radiation and chemotherapy (<a href="#R3" class="usa-link" aria-describedby="R3">3</a>), with an abysmal median overall survival of ~14 months and less than 7% five-year survival rate (<a href="#R4" class="usa-link" aria-describedby="R4">4</a>). Several factors including tumor heterogeneity, high proliferative rate, invasiveness, blood-brain-barrier (BBB), and blood-tumor-barrier (BTB) contribute to making the effective treatment of GBM a major challenge (<a href="#R5" class="usa-link" aria-describedby="R5">5</a>). Targeted therapies have shown promise in many cancer types with increased treatment efficacy and safety compared to traditional chemotherapies (<a href="#R6" class="usa-link" aria-describedby="R6">6</a>). However, targeted therapies for GBM are limited, with bevacizumab being the only FDA-approved targeted therapy and having no benefit on patient overall survival (OS) (<a href="#R7" class="usa-link" aria-describedby="R7">7</a>, <a href="#R8" class="usa-link" aria-describedby="R8">8</a>). Together, there is an urgent unmet need to identify new drug targets and new effective therapies for GBM patients.</p>
<p id="P6">Alteration in the Cyclin-dependent kinase 4/6 (CDK4/6) cell cycle pathway are common across many cancers such as breast cancer and melanoma and have been studied as targets for novel therapies (<a href="#R9" class="usa-link" aria-describedby="R9">9</a>). The high frequency of CDK4/6 pathway alterations has led to the development of multiple CDK4/6 specific inhibitors, including abemaciclib, palbociclib, and ribociclib (<a href="#R10" class="usa-link" aria-describedby="R10">10</a>). Moreover, the use of CDK4/6 inhibitors (CDK4/6is) has shown promise across multiple cancer types including lung, melanoma, colorectal, and breast cancer (<a href="#R11" class="usa-link" aria-describedby="R11">11</a>â€“<a href="#R14" class="usa-link" aria-describedby="R14">14</a>). Excitingly, these inhibitors have recently been approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone receptor-positive, HER2-negative breast cancer (<a href="#R15" class="usa-link" aria-describedby="R15">15</a>).</p>
<p id="P7">The CDK4/6 pathway has also been found to play an important role in GBM. Specifically, CDK4 overexpression has been shown to promote GBM cell growth and is correlated with worse patient survival (<a href="#R16" class="usa-link" aria-describedby="R16">16</a>). CDK4/6 have also been shown to promote a more aggressive GBM phenotype, the mesenchymal subtype, by promoting resistance to cell cycle arrest, apoptosis, and radiation resistance (<a href="#R17" class="usa-link" aria-describedby="R17">17</a>â€“<a href="#R19" class="usa-link" aria-describedby="R19">19</a>). While CDK4/6is have shown promising results in treating GBM <em>in vitro</em> and <em>in vivo</em> (<a href="#R14" class="usa-link" aria-describedby="R14">14</a>, <a href="#R20" class="usa-link" aria-describedby="R20">20</a>), multiple clinical trials assessing the use of CDK4/6 monotherapies in GBM patients have shown limited efficacy (<a href="#R13" class="usa-link" aria-describedby="R13">13</a>, <a href="#R21" class="usa-link" aria-describedby="R21">21</a>, <a href="#R22" class="usa-link" aria-describedby="R22">22</a>). This discrepancy between the data from preclinical studies and outcomes of clinical trials strongly suggests CDK4/6i resistance as a potential mechanism driving limited efficacy.</p>
<p id="P8">Truncated glioma-associated oncogene homolog 1 (tGLI1) was first discovered by our group as a novel splice variant of the zinc-finger transcription factor GLI1 with a gain-of-function downstream effect on the SHH-PTCH1-SMO axis, that has tumor-specific expression in both breast cancer and GBM (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>â€“<a href="#R25" class="usa-link" aria-describedby="R25">25</a>). tGLI1 drives the mesenchymal subtype of GBM, and promotes angiogenesis and invasion through upregulation of <em>CD24, VEGF-C, TEM7,</em> and <em>heparinase</em>, as well as, enrichment of the glioma stem cell (GSC) population through upregulating <em>CD44</em> (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>, <a href="#R26" class="usa-link" aria-describedby="R26">26</a>â€“<a href="#R28" class="usa-link" aria-describedby="R28">28</a>). Recently, we identified a tGLI1 specific inhibitor and an FDA-approved antifungal, Ketoconazole (KCZ), that specifically inhibits tGLI1-expressing breast cancer stem cells and decreases breast cancer brain metastatic burden in mouse models (<a href="#R29" class="usa-link" aria-describedby="R29">29</a>). However, KCZ-mediated inhibition of tGLI1 in GBM has not been investigated.</p>
<p id="P9">Given the GSC population plays a critical role in GBM tumor maintenance, proliferation, treatment resistance, and recurrence (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>), targeting this cell population may aid in improving treatment efficacy against GBM. Thus, in this study, we sought to characterize the role of tGLI1 in promoting CDK4/6i resistance and study the effects of KCZ+CDK4/6i combination targeted therapy against GBM using <em>in vitro</em> experiments and two orthotopic GBM xenograft models. Our data showed, for the first time, that tGLI1 renders GBM cell and GSCs more resistant to CDK4/6i treatment, tGLI1 specific knockdown potentiates the cells to CDK4/6i, and the novel KCZ+CDK4/6i combination treatment synergistically inhibited GSC formation, induced cell cycle arrest, increased apoptosis, decreased tumor growth, and reduced angiogenesis <em>in vitro</em> and <em>in vivo</em>. Furthermore, we found that tGLI1 overexpression renders GSCs more resistant to radiation (RT) and temozolomide (TMZ), and conversely, KCZ sensitizes tGLI1-expressing GSCs to radiation and TMZ treatments. Together, these findings reveal tGLI1 as a promising pharmacological target to sensitize GBM to standard-of-care as well as CDK4/6-targeted therapy.</p></section><section id="S2"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="S3"><h3 class="pmc_sec_title">CDK4/6 pathway is altered in GBMs</h3>
<p id="P10">To determine the frequency of CDK4/6 pathway alteration in GBM patients, we performed bioinformatic analyses using cBioPortal (<a href="#R31" class="usa-link" aria-describedby="R31">31</a>â€“<a href="#R33" class="usa-link" aria-describedby="R33">33</a>). After excluding isocitrate dehydrogenase mutant (IDH-mt) patients, in accordance with the current diagnostic criteria for GBM, we found that roughly 70% of GBM patients had some genetic alteration of key CDK4/6 pathway components (<a href="#F1" class="usa-link">Fig. 1A</a>). Interestingly, CDKN2A and CDKN2B deletions were the most frequent alterations in patients at 55% and 53% respectively, with the majority of patients having loss of both genes (<a href="#F1" class="usa-link">Fig. 1A</a>). Furthermore, we found alterations in other key CDK4/6 pathway components (CDK4, CDK6, RB1), to be mostly exclusive to CDKN2A/B deletion in patients (<a href="#F1" class="usa-link">Fig. 1A</a>). Patients with any CDK4/6 pathway alteration had worse overall survival (Median: 13.76 months vs 17.18 months, p&lt;0.0001) and disease-free survival (DFS) (Median: 7.10 months vs 9.56 months, p=0.0008) compared to patients without any CDK4/6 pathway alterations (<a href="#F1" class="usa-link">Fig. 1B</a>â€“<a href="#F1" class="usa-link">C</a>). While no significant difference was observed in OS or DFS in patients with only CDK4/6 amplification versus unaltered patients, OS trended to be worse in patients with CDK4/6 amplification (<a href="#SD2" class="usa-link">Supp Fig. 1</a> and <a href="#SD2" class="usa-link">2</a>). Additional patient samples from the Wake Forest Brain Tumor Tissue Bank were analyzed (N=33) which also showed that CDKN2A/B loss and CDK4/6 amplification are frequent in GBM patients (<a href="#F1" class="usa-link">Fig. 1D</a>â€“<a href="#F1" class="usa-link">E</a>). Furthermore, CDK4/6 amplifications are found in both newly diagnosed and recurrent patient samples (<a href="#F1" class="usa-link">Fig. 1E</a>). Similarly, patient samples collected at the University of Texas Health Science Center at Houston (N=281) showed similar results (<a href="#SD2" class="usa-link">Supp. Fig. 3</a>), with over two-thirds of primary and recurrent patients having alterations in the CDK4/6 pathway (<a href="#SD2" class="usa-link">Supp. Fig. 3A</a>â€“<a href="#SD2" class="usa-link">B</a>, <a href="#SD2" class="usa-link">Supp Fig. 4A</a>). Additionally, in matched primary and recurrent samples, 6% of patients showed a gained CDK4/6 pathway mutation in their recurrent sample versus primary tumor (<a href="#SD2" class="usa-link">Supp. Fig. 4B</a>). Together, these findings demonstrate the critical role of CDK4/6 pathway alterations in driving primary and recurrent GBM and the importance of inhibiting this pathway.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1: CDK4/6 pathway is altered in the majority of GBM patients.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/d64f46f4efdc/nihpp-2025.02.20.639359v1-f0001.jpg" loading="lazy" height="840" width="715" alt="Figure 1:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P36"><strong>(A)</strong> CDK4/6 pathway alterations are common in GBM patients. Oncoprint of CDK4/6 pathway genomic alterations in GBM (IDH-WT) patients generated from cBioPortal GBM datasets (N=642). <strong>(B-C)</strong> Patients with any CDK4/6 pathway alteration have worse OS and DFS compared to the unaltered group. Kaplan-Meier analysis of GBM (IDH-WT) patientsâ€™ OS and DFS with or without CDK4/6 pathway alterations from cBioPortal GBM datasets (N=642). <strong>(D)</strong> GBM patient samples (newly diagnosed and recurrent) collected at Wake Forest Comprehensive Cancer Center (WFCCC) (N=33) frequently have genomic alterations in CDKN2A/B, CDK4, or CDK6. <strong>(E)</strong> WFCCC patients have 24% CDK4 and 10% CDK6 amplification in newly diagnosed patients (N=12), and 17% CDK4 and 33% CDK6 amplification in recurrent samples (N=21). Log rank test was used to compute p-values.</p></figcaption></figure></section><section id="S4"><h3 class="pmc_sec_title">tGLI1 pathway activation is correlated with CDK4/6i resistance in GBM.</h3>
<p id="P11">Due to the lack of response to CDK4/6is as observed in multiple clinical trials, we next sought to identify potential mechanisms underlying this therapeutic resistance (<a href="#R21" class="usa-link" aria-describedby="R21">21</a>, <a href="#R22" class="usa-link" aria-describedby="R22">22</a>). Using a published CDK4/6i resistance signature (CIRS) and Gene Set Enrichment Analysis (GSEA) (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>, <a href="#R27" class="usa-link" aria-describedby="R27">27</a>), we found three cancer signaling pathways to be significantly enriched in patients with a high CIRS score (<a href="#F2" class="usa-link">Fig. 2A</a>), namely Î²-catenin, Sonic HedgeHog (SHH), and PI3K (<a href="#F2" class="usa-link">Fig. 2B</a>â€“<a href="#F2" class="usa-link">D</a>). Since it is well-established that the SHH pathway promotes GSC population, which is the known driver of treatment resistance in GBM(<a href="#R34" class="usa-link" aria-describedby="R34">34</a>), we decided to focus on investigating the SHH pathway and its potential role in CDK4/6i resistance. Given that our recent work has shown glioma GLI1 and tGLI1 as the downstream effectors of the SHH pathway (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>), we next explored GLI1 (GLI1 activation signature) and tGLI1 activity (tGLI1 activation signatureâ€”tGAS) in relation to CIRS score in GBM patients. By performing Pearson correlation analysis, we found tGLI1 activity to be significantly and positively correlated with CIRS in GBM patients, with no correlation between GLI1 and CIRS (<a href="#F2" class="usa-link">Fig. 2E</a>â€“<a href="#F2" class="usa-link">F</a>). Furthermore, patients with mesenchymal GBM (mGBM) were found to have a high CIRS/tGAS combined signature score as compared to other GBM subtypes (<a href="#F2" class="usa-link">Fig. 2G</a>). mGBM exhibits increased stemness, invasion, and treatment resistance, further suggesting the role of tGLI1-mediated GBM stemness as a potential mechanism of CDK4/6i resistance (<a href="#R35" class="usa-link" aria-describedby="R35">35</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2: tGLI1 pathway activation is positively correlated with CDK4/6 inhibitor resistance.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/f468e78f152b/nihpp-2025.02.20.639359v1-f0002.jpg" loading="lazy" height="840" width="702" alt="Figure 2:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P37"><strong>(A)</strong> Signaling pathways were analyzed for enrichment in High vs Low CIRS patients, with their respective Normalized Enrichment Scores (NES) and p-values. Î²-catenin, SHH, and PI3K pathways were the three most enriched. <strong>(B-D)</strong> Representative GSEA plots for Î²-Catenin (B), SHH (C), and PI3K (D). <strong>(E-F)</strong> tGAS, not GLI1 signature, is significantly and positively correlated with CIRS in GBM patients. Pearson correlation plot of CIRS versus GLI1 signature (E) or tGAS (F). <strong>(G)</strong> Combined CIRS/tGAS signature is highly expressed in the mesenchymal subtype of GBM patients from the <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE4290" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE4290</a> dataset. <strong>(H)</strong> Representative images of tissue microarray (GL2083) co-stained for tGLI1, CDK4, or CDK6, consisting of 30 GBM samples, 8 normal brain tissues, and 8 cancer adjacent normal tissues. <strong>(I)</strong> Corresponding values of positive expression from stained GL2083 slides showing high expression of tGLI1, CKD4/6, and tGLI1 and CDK4/6 in GBM patient samples. Fisherâ€™s exact test was used to compute p-values (<sup>1</sup>p=0.0005, <sup>2</sup>p=0.0003, and <sup>3</sup>p=0.0168 between GBM and normal/adjacent brain samples) <strong>(J)</strong> Western blot panel containing GBM cell lines, GSCs, and PDXs samples were analyzed for levels of CDK4/6 pathway proteins and tGLI1. Studentâ€™s t-test was used to compute p-values. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></figcaption></figure><p id="P12">Given the correlation between tGLI1 activity with CIRS in publicly available datasets, we next determined whether this correlation remained true in GBM patient specimens and cell lines. A tissue microarray (GL2083) containing 30 GBMs, 8 normal brain, and 8 GBM adjacent tissue samples was stained for tGLI1 and CDK4/6 proteins using immunohistochemistry (IHC) (representative images in <a href="#F2" class="usa-link">Fig. 2H</a>). Results revealed that both tGLI1 and CDK4 or CDK6 proteins were highly expressed in GBM patients (70% and 73%, respectively) with no signal in normal or tumor adjacent tissues (<a href="#F2" class="usa-link">Fig. 2H</a>â€“<a href="#F2" class="usa-link">I</a>). Additionally, 47% of patients showed co-expression of tGLI1 and CDK4/6 proteins in GBM (<a href="#F2" class="usa-link">Fig. 2H</a>â€“<a href="#F2" class="usa-link">I</a>). Western blot analysis using multiple GBM cell lines, GSCs, and patient derived xenograft (PDX) samples revealed that tGLI1 is co-expressed with CDK4/6 in the majority of the GBM samples tested (<a href="#F2" class="usa-link">Fig. 2J</a>). Additionally, E2F Transcription Factor 1 (E2F1) and Forkhead Box M1 (FOXM1), two downstream targets of the CDK4/6 pathway, were also highly expressed in tGLI1 positive GBM lines (<a href="#F2" class="usa-link">Fig. 2J</a>). Of note, loss of Rb and CDK6 was observed in some of the cell lines, which have been shown to play an important role in promoting CDK4/6i resistance. Thus, G48 (CDK6+ and Rb+) and GSC28 (CDK6âˆ’ and Rbâˆ’) lines were selected as representative cell lines for downstream analysis (<a href="#F2" class="usa-link">Fig. 2J</a>) (<a href="#R36" class="usa-link" aria-describedby="R36">36</a>). Together, these data show that tGLI1 and CDK4/6 pathway proteins are co-expressed in GBM, suggesting that tGLI1 activity is correlated with the observed CDK4/6i resistance in patients.</p></section><section id="S5"><h3 class="pmc_sec_title">tGLI1 promotes GBM resistance to CDK4/6i in vitro.</h3>
<p id="P13">The GSC population is one of the primary drivers of GBM treatment resistance. Therefore, we next investigated the role of tGLI1 in promoting CDK4/6i resistance in the GSC population. Neurosphere formation assays, to enrich the stem cell population, were performed using G48 and GSC-28 cell lines stably overexpressing a vector, GLI1, or tGLI1 with CDK4/6i treatment (abemaciclib or palbociclib) (<a href="#F3" class="usa-link">Fig. 3A</a>â€“<a href="#F3" class="usa-link">E</a>). tGLI1-overexpressing G48-tGLI1 and GSC-28-tGLI1 lines demonstrated greater resistance to abemaciclib treatment as compared to their vector and GLI1 controls (<a href="#F3" class="usa-link">Fig. 3A</a>â€“<a href="#F3" class="usa-link">B</a>; <a href="#SD2" class="usa-link">Supp. Fig.6A</a> and <a href="#SD2" class="usa-link">6B</a>). Similar results were found with Palbociclib treatment (<a href="#F3" class="usa-link">Fig. 3C</a>â€“<a href="#F3" class="usa-link">D</a>; <a href="#SD2" class="usa-link">Supp. Fig. 6C</a> and <a href="#SD2" class="usa-link">6D</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3: tGLI1 promotes GBM resistance to CDK4/6 inhibitors <em>in vitro.</em>
</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/0496eb686770/nihpp-2025.02.20.639359v1-f0003.jpg" loading="lazy" height="1050" width="785" alt="Figure 3:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P38"><strong>(A-B)</strong> Isogenic G48 (A) or GSC-28 (B) vector, GLI1, and tGLI1 neurospheres were treated with increasing doses of abemaciclib. tGLI1 lines showed increased resistance to abemaciclib treatment. <strong>(C-D)</strong> Isogenic G48 (C) or GSC-28 (D) vector, GLI1, and tGLI1 neurospheres were treated with increasing doses of palbociclib. tGLI1 lines showed increased resistance to palbociclib treatment. <strong>(E-F)</strong> Isogenic G48 (E) or GSC-28 (F) -vector, -GLI1, and -tGLI1 neurospheres were treated with increasing doses of KCZ. KCZ selectively inhibited tGLI1 neurosphere formation. <strong>(G-H)</strong> Immortalized human astrocytes were treated with KCZ (2.5 and 5 Î¼M) (G), Palbociclib (0.5 Î¼M) or abemaciclib (5 Î¼M). Treatment of all three drugs showed no signs of decreased cell viability (H). Studentâ€™s t-test was used to compute p-values. *p&lt;0.05 compared to vector group at the same does; ^p&lt;0.05 compared to GLI1 group at the same dose.</p></figcaption></figure><p id="P14">KCZ, an FDA approved anti-fungal, has previously been shown to specifically inhibit tGLI1 in breast cancer brain metastasis (<a href="#R29" class="usa-link" aria-describedby="R29">29</a>). Since KCZ permeates the BBB (<a href="#R29" class="usa-link" aria-describedby="R29">29</a>), we next investigated the efficacy of KCZ in tGLI1-overexpressing GBM lines. We observed that KCZ selectively inhibited GSC formation in both G48-tGLI1 and GSC-28-tGLI1 lines as compared to vector and GLI1 controls (<a href="#F3" class="usa-link">Fig. 3E</a>â€“<a href="#F3" class="usa-link">F</a>). Immortalized human astrocytes were treated with KCZ (<a href="#F3" class="usa-link">Fig. 3G</a>) or CDK4/6is (<a href="#F3" class="usa-link">Fig. 3H</a>) to determine potential treatment toxicity to brain parenchymal cells and no significant effects were observed on cell viability. Together, these results suggest that tGLI1 promotes CDK4/6 inhibitor resistance, and KCZ effectively inhibits tGLI1.</p></section><section id="S6"><h3 class="pmc_sec_title">KCZ+Abemaciclib combination therapy significantly reduces GSCs and GBM stemness in vitro.</h3>
<p id="P15">While monotherapies have shown promise in various cancer types, combination therapies have exhibited greater effectiveness. In our study, we have shown the co-upregulation of the tGLI1 and CDK4/6 pathway in GBM, suggesting a potential therapeutic benefit through co-inhibition (<a href="#F2" class="usa-link">Fig. 2</a>). Thus, we next investigated the novel combination of KCZ and CDK4/6is, abemaciclib or palbociclib. G48-tGLI1 and GSC-28-tGLI1 cells were grown as neurospheres and were treated with vehicle, KCZ, abemaciclib/palbociclib, or combination at varying therapeutic ratios. Combination indices (CI) at different effective doses (EDs) were generated by the Chou and Talalay method, with CI&lt;1 indicating synergism, while CI&gt;1 indicates antagonism (<a href="#F4" class="usa-link">Fig. 4A</a>, <a href="#F4" class="usa-link">B</a>) (<a href="#R37" class="usa-link" aria-describedby="R37">37</a>). Combination treatment of KCZ and abemaciclib at a 5:1 ratio was synergistic in G48-tGLI1 neurospheres and significantly inhibited sphere formation compared to vehicle and single treatment (<a href="#F4" class="usa-link">Fig. 4A</a>, <a href="#F4" class="usa-link">C</a>). Combination ratios of 10:1, 5:1, and 2:1 were synergistic against GSC-28 tGLI1 spheres, significantly reducing sphere formation compared to vehicle and single treatment groups (<a href="#F4" class="usa-link">Fig. 4A</a>, <a href="#F4" class="usa-link">E</a>). Similar results were found when combining KCZ with Palbociclib (<a href="#F4" class="usa-link">Fig. 4B</a>, <a href="#F4" class="usa-link">D</a>, <a href="#F4" class="usa-link">F</a>). These results demonstrate that KCZ-mediated inhibition of tGLI1 could potentially sensitize GBM to CDK4/6i treatment.</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4: KCZ+abemaciclib Combination therapy significantly reduces GSCs and GBM stemness <em>in vitro.</em>
</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/4afb65f4710d/nihpp-2025.02.20.639359v1-f0004.jpg" loading="lazy" height="840" width="687" alt="Figure 4:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P39"><strong>(A-B)</strong> G48-tGLI1 and GSC-28-tGLI1 lines were grown as neurospheres and treated with combination therapy of KCZ+abemaciclib (A) or KCZ+palbociclib (B) at multiple combination ratios, as depicted in the respective tables. Combination index (CI) was computed using Calcusyn based on the results of neurosphere formation assay. CI&lt;1 means synergism, CI=1 means addition, and CI&gt;1 means antagonism. Synergistic combination ratios are highlighted in red. <strong>(C-F)</strong> Representative neurosphere results of synergistic combination ratios in both G48-tGLI1 and GSC-28-tGLI1 lines. Studentâ€™s t-test was used to compute p-values. Representative comparisons are labelled *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, or ****p&lt;0.0001 between two groups.</p></figcaption></figure></section><section id="S7"><h3 class="pmc_sec_title">KCZ+Abemaciclib combination therapy significantly decreases GBM proliferation and promotes apoptosis in vitro</h3>
<p id="P16">Treatment with CDK4/6is results in cell cycle arrest in breast cancer [38]. Therefore, we next evaluated the efficacy of single or combination treatment in inducing cell cycle arrest in G48-tGLI1 and GSC28-tGLI1 lines by staining with 7-AAD, a fluorescent chemical compound to label DNA (<a href="#R38" class="usa-link" aria-describedby="R38">38</a>) (<a href="#F5" class="usa-link">Fig. 5A</a>â€“<a href="#F5" class="usa-link">B</a>, <a href="#SD2" class="usa-link">Supp. Figs 7</a> and <a href="#SD2" class="usa-link">8</a>). Results showed that KCZ treatment alone had no significant effect on altering cell cycle progression in G48-tGLI1 cells (<a href="#F5" class="usa-link">Fig. 5A</a>). However, treatment with abemaciclib and the combination significantly promoted G1 arrest (<a href="#F5" class="usa-link">Fig. 5A</a>). Interestingly, only combination treatment significantly promoted cell cycle arrest in G2 in the GSC-28-tGLI1, demonstrating the effectiveness of the combination therapy (<a href="#F5" class="usa-link">Fig. 5B</a>). The difference in treatment response across the two cell lines may be due to their different Rb status. The GSC-28-tGLI1 cells are Rb deficient and thus lack regulation of E2F1 and FOXM1 that subsequently contributes to CDK4/6i resistance, which is overcome with combination therapy with CDK4/6i and KCZ.</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5: KCZ+abemaciclib combination therapy significantly decreases GBM proliferation and promotes apoptosis <em>in vitro.</em>
</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/920ff88de7ec/nihpp-2025.02.20.639359v1-f0005.jpg" loading="lazy" height="840" width="645" alt="Figure 5:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P40"><strong>(A-B)</strong> Combination therapy significantly inhibits cell cycle progression in G48-tGLI1 (A) and GSC-28-tGLI1 (B) cell lines. Cells were treated with vehicle, KCZ (5 Î¼M), abemaciclib (1Î¼M), or KCZ+abemaciclib combination for 24 hours. Studentâ€™s t-test was used to compute p-values. *p&lt;0.05 compared to control in %cells of G1 phase, ^p&lt;0.05 compared to abemaciclib-only group in % cells of G1 phase. <strong>(C-D</strong>) G48-tGLI1 (C) or GSC-28-tGLI1 (D) cells treated with vehicle, KCZ (5Î¼M), abemaciclib (1Î¼M), or KCZ+abemaciclib combination for 24 hours and then subjected to Annexin V-FITC/7-AAD flow cytometry. Combination therapy significantly promoted apoptosis in both cell lines. Representative flow cytometry diagrams are shown on the right. Studentâ€™s t-test was used to compute p-values. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 between two groups.</p></figcaption></figure><p id="P17">Cell cycle arrest often leads to cell death, therefore, we next investigated changes in apoptosis following single or combination therapies (<a href="#R39" class="usa-link" aria-describedby="R39">39</a>). G48-tGLI1 and GSC-28-tGLI1 cell lines were subjected to vehicle, single agent, or combination therapy for 24 hours, and then stained with Annexin V-FITC/7-AAD and analyzed by flow cytometry analysis to assess apoptosis (<a href="#F5" class="usa-link">Fig. 5C</a>â€“<a href="#F5" class="usa-link">D</a>). Results showed that while both single treatments significantly increased apoptosis in G48-tGLI1 cells as compared to vehicle, combination treatment significantly increased apoptosis compared to the other two groups(<a href="#F5" class="usa-link">Fig. 5C</a>). Similar results were observed in GSC-28-tGLI1 (<a href="#F5" class="usa-link">Fig. 5D</a>). These results further confirm the synergy between tGLI1 and CDK4/6 inhibition in GBM, by promoting cell cycle arrest and increasing GBM apoptosis <em>in vitro</em>.</p></section><section id="S8"><h3 class="pmc_sec_title">KCZ+Abemaciclib Combination therapy significantly decreases tumor growth in vivo.</h3>
<p id="P18">To assess the translatability of our findings, we investigated the efficacy of this combination therapy <em>in vivo</em>. G48-tGLI1 cells containing a luciferase reporter were intracranially implanted into the right frontal lobe of female athymic nude mice. After a 10 day period of tumor engraftment, animals were randomized, after which mice were treated with vehicle, KCZ (50 mg/kg, intra-peritoneal) only, abemaciclib (50 mg/kg, oral gavage) only, or KCZ+abemaciclib combination therapy for ~28 days (n=9â€“10 mice/ group). Combination therapy significantly inhibited tumor growth as compared to control, while single treatment had no significant effect (<a href="#F6" class="usa-link">Fig. 6A</a>â€“<a href="#F6" class="usa-link">B</a>, <a href="#SD2" class="usa-link">Supp Fig.9</a>). All treatment groups were well tolerated as determined through an alanine transaminase assay (ALT) to determine liver toxicity and monitoring of mouse weight over the course of the study (<a href="#F6" class="usa-link">Fig. 6C</a>â€“<a href="#F6" class="usa-link">D</a>).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Figure 6: KCZ+abemaciclib combination therapy significantly decreases tumor growth <em>in vivo.</em>
</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/abf5c16b7743/nihpp-2025.02.20.639359v1-f0006.jpg" loading="lazy" height="839" width="703" alt="Figure 6:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P41"><strong>(A)</strong> Combination treatment significantly reduced tumor growth in mice. Growth curve of G48-tGLI1 intracranial tumors across control, KCZ, abemaciclib, and combination groups. <strong>(B)</strong> Representative IVIS images at 27 days after intracranial inoculation. <strong>(C)</strong> Blood ALT levels were not significantly increased in any treatment group. <strong>(D)</strong> No significant change in mouse weight was seen across all treatment groups. <strong>(E)</strong> Combination treatment significantly increased GBM apoptosis <em>in vivo.</em> TUNEL staining conducted on sectioned mouse brains across control, KCZ, abemaciclib, and combination groups. <strong>(F)</strong> Representative TUNEL staining images. <strong>(G)</strong> IHC staining of sectioned mouse brains stained for Ki-67 and mCD31. Combination treatment significantly decreased GBM proliferation and microvessel formation <em>in vivo</em>. <strong>(H-I)</strong> Corresponding graphs for Ki-67 (H) and mCD31 (I) IHC staining. Studentâ€™s t-test was used to calculate p-values.</p></figcaption></figure><p id="P19">Mouse brains were harvested to be analyzed for changes in tumor proliferation, angiogenesis, and cell death following treatment using IHC. The combination therapy significantly increased Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) positive cells as compared to vehicle and single treatment groups, demonstrating increased tumor apoptosis (<a href="#F6" class="usa-link">Fig. 6E</a>â€“<a href="#F6" class="usa-link">F</a>). Furthermore, treatment with both agents significantly increased cell death as compared to vehicle (<a href="#F6" class="usa-link">Fig. 6E</a>â€“<a href="#F6" class="usa-link">F</a>). Additionally, mouse brain sections were stained with Ki-67 and mCD31 to determine changes in tumor proliferation and microvessel formation, respectively. Results showed a significant decrease in Ki-67 positivity following combination therapy compared to vehicle and single treatment groups, while either single treatment had no significant change compared to vehicle (<a href="#F6" class="usa-link">Fig. 6G</a>â€“<a href="#F6" class="usa-link">H</a>). Furthermore, microvessel formation was significantly inhibited by combination therapy when compared to vehicle and KCZ alone groups (<a href="#F6" class="usa-link">Fig. 6G</a> and <a href="#F6" class="usa-link">I</a>). These results demonstrate that the KCZ+abemaciclib combination therapy retains their synergistic effect <em>in vivo</em>, significantly inhibiting GBM growth and promoting apoptosis.</p></section><section id="S9"><h3 class="pmc_sec_title">KCZ+Abemaciclib combination therapy inhibits PDX39 growth in an intracranial mouse model.</h3>
<p id="P20">To further validate the efficacy of KCZ+abemaciclib combination therapy against GBM in a more clinically relevant <em>in vivo</em> model, we utilized a second orthotopic xenograft mouse model using the highly aggressive PDX 39 line that is positive for tGLI1 and CDK4/6 expression (<a href="#F2" class="usa-link">Fig. 2J</a>). Female athymic nude mice were intracranially inoculated with PDX39 cells containing a luciferase reporter into the right frontal lobe and animals were treated with vehicle, KCZ (50 mg/kg), abemaciclib (50 mg/kg), or combination therapy for 20 days (<a href="#F7" class="usa-link">Fig. 7A</a>). Following termination, brains were harvested and underwent <em>ex vivo</em> imaging, where results showed a significant reduction in brain bioluminescence in the combination therapy group, as compared to all other treatment groups (<a href="#F7" class="usa-link">Fig. 7B</a>â€“<a href="#F7" class="usa-link">C</a>). Additionally, there was no significant change in mouse weight over the course of treatment, indicating that treatment was well tolerated (<a href="#F7" class="usa-link">Fig. 7D</a>). These results, along with the results from our previous animal study (<a href="#F6" class="usa-link">Fig. 6</a>), highlight the efficacy and safety of the synergistic KCZ+abemaciclib combination therapy <em>in vivo</em>.</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Figure 7: KCZ+abemaciclib combination therapy inhibits PDX39 growth in an intracranial mouse model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/03e41687809e/nihpp-2025.02.20.639359v1-f0007.jpg" loading="lazy" height="1050" width="773" alt="Figure 7:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P42"><strong>(A)</strong> Animal study schematic. Mice were intracranially inoculated with PDX39 luciferase expressing cells in the right frontal lobe. Tumors were allowed to establish for 10 days before randomization and the beginning of treatment. The study was terminated 30 days after inoculation. <strong>(B)</strong>
<em>Ex vivo</em> brain bioluminescence of control, KCZ, abemaciclib, and combination groups. Combination therapy significantly reduced PDX39 growth <em>in vivo</em>. <strong>(C)</strong> Representative <em>ex vivo</em> brain images. <strong>(D)</strong> No significant change in mouse weight was seen across all treatment groups. Studentâ€™s t-test was used to calculate p-values.</p></figcaption></figure></section><section id="S10"><h3 class="pmc_sec_title">tGLI1 promotes resistance to GBM standard-of-care therapy and KCZ overcomes this resistance.</h3>
<p id="P21">Radiation therapy is a major component of the standard-of-care therapy for GBM patient, however, GSCs have been shown to promote radiation resistance (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>, <a href="#R40" class="usa-link" aria-describedby="R40">40</a>, <a href="#R41" class="usa-link" aria-describedby="R41">41</a>). We have previously shown tGLI1 promotes the GSC population, therefore, we next investigated tGLI1 expression and GBM radiation resistance (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>â€“<a href="#R28" class="usa-link" aria-describedby="R28">28</a>). Isogenic G48-vector, -GLI1, and -tGLI1 stable lines were exposed to 0 gray (Gy) or 5 Gy of ionizing radiation (IR), and were then seeded in monolayer or sphere forming conditions (<a href="#F8" class="usa-link">Fig. 8A</a>â€“<a href="#F8" class="usa-link">B</a>). Interestingly, tGLI1 overexpression had no effect on G48 cells grown in monolayer conditions, but significantly promoted survival in neurosphere following IR (<a href="#F8" class="usa-link">Fig. 8A</a>â€“<a href="#F8" class="usa-link">B</a>; <a href="#SD2" class="usa-link">Supp. Fig. 10</a>). Similar results were seen with GLI1 and tGLI1 overexpressing GSC-28 neurospheres, which are more resistant to 2 Gy of IR treatment as compared to GSC-28-vector cells (<a href="#F8" class="usa-link">Fig. 8C</a>).</p>
<figure class="fig xbox font-sm" id="F8"><h4 class="obj_head">Figure 8: tGLI1 promotes resistance to GBM standard-of-care therapy and KCZ overcomes the resistance.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11888219_nihpp-2025.02.20.639359v1-f0008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7c/11888219/0c22143eb71b/nihpp-2025.02.20.639359v1-f0008.jpg" loading="lazy" height="840" width="676" alt="Figure 8:"></a></p>
<div class="p text-right font-secondary"><a href="figure/F8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P44"><strong>(A-B)</strong> tGLI1 overexpression promoted radioresistance in isogenic G48 neurospheres, but not monolayer. Isogenic G48 vector, GLI1, and tGLI1 were treated with 0 Gy or 5 Gy of radiation therapy (RT), and then seeded in monolayer (A) or sphere forming conditions (B). <strong>(C)</strong> GSC-28-GLI1 and tGLI1 lines were more resistant to RT. Isogenic GSC-28 vector, GLI1, and tGLI1 cells were treated with 0 Gy or 2 Gy of RT, and then seeded in sphere forming conditions. <strong>(D-E)</strong> G48-tGLI1 and GSC-28-tGLI1 lines are resistant to RT, abemaciclib, and RT+abemaciclib combination treatment compared to vector and GLI1 lines. Isogenic G48 (D) or GSC-28 (E) vector, GLI1 and tGLI1 cells were treated with vehicle, RT (5 Gy forG48; 2 Gy for GSC-28), abemaciclib (1 Î¼M), or RT+abemaciclib combination and seeded in sphere forming conditions. <strong>(F-G)</strong> G48-tGLI1 and GSC-28-tGLI1 lines were resistant to RT, Palbociclib, and RT+palbociclib compared to vector and GLI1 lines. Isogenic G48 (D) or GSC-28 (E) -vector, -GLI1 and -tGLI1 cells were treated with vehicle, RT (5 Gy for G48; 2 Gy for GSC-28), Palbociclib (5 Î¼M for G48; 1 Î¼M for GSC-28), or RT+palbociclib combination and seeded in neurosphere forming conditions. <strong>(H)</strong> G48-tGLI1 cells had increased sensitivity to TMZ treatment when combined with KCZ treatment. G48-tGLI1 cells were grown in sphere forming conditions and treated with vehicle, TMZ (100 Î¼M), KCZ (2.5 Î¼M), or TMZ+KCZ combination therapy and spheres were counted. Studentâ€™s t-test and One-way ANOVA was used to calculate p-values.</p></figcaption></figure><p id="P22">Next, we investigated changes in neurosphere forming abilities following radiation alone (5 Gy for G48, 2 Gy for GSC-28), CDK4/6i treatment alone, or combination in G48 and GSC-28 isogenic stable lines. Interestingly, we found tGLI1-overexpressing G48-tGLI1 and GSC-28-tGLI1 cells to be more resistant to radiation alone, abemaciclib (1Î¼M in both cell lines) alone, and combination therapy as compared to their respective vector and GLI1 lines (<a href="#F8" class="usa-link">Fig. 8D</a>â€“<a href="#F8" class="usa-link">E</a>). Similar results were seen with the use of Palbociclib (5Î¼M for G48 and 1Î¼M for GSC-28) in G48 and GSC-28 isogenic stable lines (<a href="#F8" class="usa-link">Fig. 8F</a>â€“<a href="#F8" class="usa-link">G</a>). Together, these results demonstrate that tGLI1 promotes radiation resistance, specifically in the GSC population. This is further supported by the observation that combined radiation and CDK4/6i treatment is less effective against tGLI1-overexpressing GBM in inhibiting neurosphere formation.</p>
<p id="P23">In addition to radiation, TMZ treatment is a second component of the standard-of-care therapy for GBM patients (<a href="#R3" class="usa-link" aria-describedby="R3">3</a>). We further investigated the role of tGLI1 in TMZ resistance in GBM. We treated isogenic G48-tGLI1 spheres with vehicle, 2.5 Î¼M KCZ alone, 100 Î¼M TMZ alone, or KCZ+TMZ combination therapy and counted neurospheres on day 5 following the initial treatment. Results showed KCZ and TMZ monotherapy significantly reduced sphere formation compared to vehicle (<a href="#F8" class="usa-link">Fig. 8H</a>). Importantly, the combination treatment was the most effective in reducing neurosphere formation compared to all other groups (<a href="#F8" class="usa-link">Fig. 8H</a>). Together, results in <a href="#F8" class="usa-link">Fig. 8</a> demonstrated that tGLI1 promotes resistance to GBM standard-of-care therapy and KCZ overcomes the resistance</p></section></section><section id="S11"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p id="P24">CDK4/6is have shown promise in effective treatment of different cancer types and are now in clinic with FDA approval for treating hormone receptor-positive breast cancers and tumors with loss of p16<sup>INK4a</sup> or increased cyclin D1 (<a href="#R42" class="usa-link" aria-describedby="R42">42</a>). Unfortunately, clinical trials in GBM patients have not yielded positive results in improvement of OS or progression-free survival (PFS) owing to therapeutic resistance in this tumor type (<a href="#R13" class="usa-link" aria-describedby="R13">13</a>, <a href="#R21" class="usa-link" aria-describedby="R21">21</a>, <a href="#R22" class="usa-link" aria-describedby="R22">22</a>). Following investigation of underlying mechanisms of resistance, we report that tGLI1 promotes GBM resistance to CDK4/6i. We also found that tGLI1 overexpression promotes tumor resistance to RT and TMZ that are postoperative standard-of-care therapies for GBM. Recent work in our lab has demonstrated that tGLI1 is enriched in mGBM, an aggressive subtype of GBM that exhibits characteristics of increased stemness, drug resistance, and tumor invasion (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>, <a href="#R35" class="usa-link" aria-describedby="R35">35</a>, <a href="#R43" class="usa-link" aria-describedby="R43">43</a>). Moreover, our group has also shown that tGLI1 plays a critical role in enriching the GSC population by promoting mGBM. Other studies have shown that the GSC population plays a pivotal role in treatment resistance to RT, chemotherapies, and other targeted therapies such as bevacizumab in GBM (<a href="#R30" class="usa-link" aria-describedby="R30">30</a>, <a href="#R35" class="usa-link" aria-describedby="R35">35</a>). Thus, we speculate that one of the ways tGLI1 leads to treatment resistance is by increasing glioma stemness (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>, <a href="#R27" class="usa-link" aria-describedby="R27">27</a>). However, there may be multiple pathways interplaying in the tGLI1-mediated resistance to CDK4/6is in GBM. Previous work from our group reported that tGLI1 overexpressing GBM cells have increased murine double minute 2 (MDM2) expression, a reported factor that promotes GBM CDK4/6i resistance (<a href="#R23" class="usa-link" aria-describedby="R23">23</a>, <a href="#R44" class="usa-link" aria-describedby="R44">44</a>). Moreover, we have previously identified the novel interaction between tGLI1 and STAT3, with STAT3 also being reported to promote CDK4/6i resistance in breast cancer (<a href="#R27" class="usa-link" aria-describedby="R27">27</a>, <a href="#R45" class="usa-link" aria-describedby="R45">45</a>). However, the role of these two factors in mediating CDK4/6i resistance in the context of tGLI1-overexpressing GBM has not been studied and warrants further investigations.</p>
<p id="P25">Another key aspect of our work is the demonstration of increased treatment efficacy with a combination therapy of CDK4/6is and KCZ, which strongly suggests the therapeutic value of targeting tGLI1 in GBM to unleash the full potential of CDK4/6is. tGLI1 is a terminal effector of the SHH pathway, one of the pathways that significantly correlated with CIRS. Two additional pathways, namely, Î²-catenin and PI3K pathways, are also significantly correlated with CIRS. In a recent study, combination of Wnt/Î²-catenin inhibitor (AC1Q3QWB) with palbociclib was synergistic against GBM in mouse models (<a href="#R46" class="usa-link" aria-describedby="R46">46</a>). Additionally, combination of PI3K/AKT/mTOR pathway inhibitors sensitized breast cancer lines to CDK4/6is , with similar results being seen in GBM (<a href="#R47" class="usa-link" aria-describedby="R47">47</a>, <a href="#R48" class="usa-link" aria-describedby="R48">48</a>). Furthermore, combining CDK4/6is with immunotherapies have shown increased efficacy in breast cancer models and brain metastasis studies (<a href="#R49" class="usa-link" aria-describedby="R49">49</a>, <a href="#R50" class="usa-link" aria-describedby="R50">50</a>). Taking these studies into consideration, there is a need for further investigation of novel combination targeted therapeutics that can overcome treatment resistance in GBM.</p>
<p id="P26">Our findings have significant translational implications in overcoming tumor treatment resistance to CDK4/6is, RT, and TMZ and preventing tumor progression while effectively treating GBM using a novel combination therapy. In patient specimens and <em>in vitro</em> GBM models, we found that tGLI1 pathway activation is highly correlated with the CDK4/6 pathway. Moreover, we demonstrated that tGLI1 promotes CDK4/6i resistance in GBM and that dual inhibition of tGLI1 and CDK4/6 with KCZ and CDK4/6is has synergistic treatment effects <em>in vitro</em> and <em>in vivo</em>. Also, tGLI1 promotes GBM resistance to RT, with modest effects in sensitization to RT when treated with CDK4/6 inhibitors. Lastly, we showed that KCZ sensitizes GBM to TMZ treatment prolonging the treatment window with standard-of-care chemotherapy. All-in-all, our study demonstrates that tGLI1 is a novel targetable transcription factor contributing to CDK4/6i and chemoradiation resistance in GBM. Importantly, congruent to our findings in metastatic breast cancer to the brain, we also showed that KCZ, FDA-approved antifungal agent that crosses the BBB, is a viable therapeutic agent that selectively binds to tGLI1 and overcomes CDK4/6i resistance in GBM (<a href="#R29" class="usa-link" aria-describedby="R29">29</a>). Thus, treating GBM with a combination therapy of KCZ and CDK4/6is may maximize the full potential of CDK4/6i in treating GBM. Further investigation is warranted in clinical trials to evaluate the efficacy of this drug combination in the clinic.</p></section><section id="S12"><h2 class="pmc_sec_title">METHODS</h2>
<section id="S13"><h3 class="pmc_sec_title">Establishment of Stable Isogenic Cell Lines.</h3>
<p id="P27">The isogenic G48LL2 and GSC28 cell lines stably expressing vector, GLI1 or tGLI1, were generated as previously described (<a href="#R27" class="usa-link" aria-describedby="R27">27</a>).</p></section><section id="S14"><h3 class="pmc_sec_title">Cell Viability Assay.</h3>
<p id="P28">Cells were seeded at a concentration of 2,000 cells/well in 96-well white bottom plates (Greiner Bio-One; KremsmÃ¼nster, Austria), and incubated at 37Â°C, 5% CO<sub>2</sub> for 24 hours. Cells were treated with test compounds for 48 hours. Viability was determined using the CellTiter-Blue Cell Viability Assay (Promega; Madison, WI, USA) according to the manufacturerâ€™s instructions. Fold changes over vehicle at various doses were computed.</p></section><section id="S15"><h3 class="pmc_sec_title">Western Blot.</h3>
<p id="P29">Western blots were performed as previously described (<a href="#R6" class="usa-link" aria-describedby="R6">6</a>). Antibodies used for western blot included CDK4 (Cell Signaling Technology (CST); #12790), CDK6 (CST; #13331), Rb (Cell signaling; 9309), E2F1 (CST; #3742), Cyclin D1 (CST; 2922), FOXM1 (CST; #20495), Î±-tubulin (Sigma-Aldrich; T6074), Î²actin (Sigma-Aldrich; T4026), GLI1 (CST; #2643), and the rabbit polyclonal tGLI1 antibody that was developed and validated by our laboratory (<a href="#R25" class="usa-link" aria-describedby="R25">25</a>, <a href="#R28" class="usa-link" aria-describedby="R28">28</a>, <a href="#R29" class="usa-link" aria-describedby="R29">29</a>, <a href="#R43" class="usa-link" aria-describedby="R43">43</a>).</p></section><section id="S16"><h3 class="pmc_sec_title">TUNEL Assay.</h3>
<p id="P30">TUNEL assay was used to determine the extent of apoptosis. Xenograft-bearing brain samples were embedded in OCT medium and were sectioned using a cryostat. Brain sections were subjected to TUNEL assay using the Click-iT Plus TUNEL Assay (Invitrogen) according to the manufacturerâ€™s instructions. Following nuclear counterstaining by DAPI (Invitrogen), the slides were imaged by fluorescence microscope (Zeiss). Apoptotic index was generated by calculating the percentage of TUNEL positive cells for each animal.</p></section><section id="S17"><h3 class="pmc_sec_title">Flow Cytometry Analysis.</h3>
<p id="P31">For apoptosis analysis, cells were harvested and washed with PBS after 24-hour treatment. A total of 1.5Ã—10<sup>6</sup> cells per group were suspended in 1mL 1X binding buffer from Annexin V-FITC Apoptosis Staining / Detection Kit (abcam, #14085), after which cells were stained with 10Î¼L Annexin V-FITC and 10Î¼L 7-AAD (abcam, #228563, 50 Î¼g/mL). For cell cycle phase distribution analysis, the cells were harvested and washed by PBS after 24-hour treatment. A total of 6Ã—10<sup>6</sup> cells per group were fixed by ice-cold 70% ethanol. The cells were stained by 7-AAD (25 Î¼g/mL) after two PBS washes. Stained cells for apoptotic or cell cycle analysis were detected by BD LSRFortessa X-20 Analyzer within 2 hours. The data were collected and analyzed by FlowJo<sup>â„¢</sup> software (BD Biosciences).</p></section><section id="S18"><h3 class="pmc_sec_title">In vivo studies.</h3>
<p id="P32">Female athymic nude (nu/nu) mice (5â€“6 weeks old; Charles River Laboratories; Wilmington, MA) were used. All mice were housed in a pathogen-free facility of the Animal Research Program at Wake Forest School of Medicine (WFSM) under a 12:12- hour light/dark cycle and were fed with sterile rodent chow <em>ad libitum.</em> Animal handling and procedures were approved by the WFSM Institutional Animal Care and Use Committee (IACUC) (protocol #A20â€“076). A total of 1 Ã— 10<sup>5</sup> G48 cells stably expressing a tGLI1 expression vector (G48-TGLI1) in 5 Î¼L PBS were injected into the right frontal lobe of anesthetized female athymic nude (nu/nu) mice (5â€“6 weeks old). Cells were allowed to engraft for 10 days. Then, mice were randomized into control (100% PEG-300), 50 mg/kg KCZ, 50 mg/kg abemaciclib, or the combination therapy groups according to the visualization of brain bioluminescent signal. KCZ was formulated in 100% PEG-300 and was administered three times per week by intraperitoneal (IP) injection. abemaciclib was formulated in 100% PBS and was administered every day by oral gavage. Tumor progression was monitored by biweekly bioluminescent imaging during which xenograft bearing mice were injected IP with 100 mg/kg D-luciferin (Perkin Elmer) and imaged using the IVIS Lumina LT Series III imager (Perkin Elmer) after 5-minute incubation. Tumor burden was analyzed by quantifying total bioluminescent signal in brain by the Living Image software version 4.7.2 (Perkin Elmer).</p></section><section id="S19"><h3 class="pmc_sec_title">Statistical Analysis.</h3>
<p id="P33">The values were presented as mean Â± SD unless noted otherwise. Studentâ€™s t-test, Log-rank test, Two-way ANOVA and Fisherâ€™s exact test were performed to determine the difference between groups using GraphPad Prism 9 or Microsoft Excel.</p></section></section><section id="SM1"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="SD1"><div class="caption p"><span>Supplement 1</span></div>
<div class="media p" id="d67e899"><div class="caption">
<a href="/articles/instance/11888219/bin/media-1.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-1.pdf</a><sup> (150.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD2"><div class="caption p"><span>Supplement 2</span></div>
<div class="media p" id="d67e902"><div class="caption">
<a href="/articles/instance/11888219/bin/media-2.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-2.pdf</a><sup> (518.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD3"><div class="caption p"><span>Supplement 3</span></div>
<div class="media p" id="d67e905"><div class="caption">
<a href="/articles/instance/11888219/bin/media-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-3.pdf</a><sup> (1.4MB, pdf) </sup>
</div></div></section></section><section id="S20" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p id="P34">We acknowledge funding support for this study from NIH grants R01CA228137 (H-WL), R21CA286225 (H-WL) and UE5NS113757 (AC and NT)( Research Education Programs for Residents &amp; Fellows), DoD grants W81XWH-19â€“1-0072 (H-WL), W81XWH-20â€“1-0044 (H-WL), W81XWH-19â€“1-0753 (H-WL), and HT9425â€“24-1â€“0889 (H-WL), as well as, MetaVivor Translational Research Grant (H-WL) and UTStars (H-WL).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN3"><p id="P35"><strong>Conflict of Interests:</strong> Authors disclose no conflict of interests.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Villa C, Miquel C, Mosses D, Bernier M, and Di Stefano AL. The 2016 World Health Organization classification of tumours of the central nervous system. La Presse MÃ©dicale. 2018;47(11, Part 2):e187â€“e200.
</cite> [<a href="https://doi.org/10.1016/j.lpm.2018.04.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30449638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=La%20Presse%20M%C3%A9dicale&amp;title=The%202016%20World%20Health%20Organization%20classification%20of%20tumours%20of%20the%20central%20nervous%20system&amp;author=C%20Villa&amp;author=C%20Miquel&amp;author=D%20Mosses&amp;author=M%20Bernier&amp;author=AL%20Di%20Stefano&amp;volume=47&amp;issue=11,%20Part%202&amp;publication_year=2018&amp;pages=e187-e200&amp;pmid=30449638&amp;doi=10.1016/j.lpm.2018.04.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. 
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016â€”2020. Neuro-oncology. 2023;25(Supplement_4):iv1â€“iv99.
</cite> [<a href="https://doi.org/10.1093/neuonc/noad149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10550277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37793125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro-oncology&amp;title=CBTRUS%20Statistical%20Report:%20Primary%20Brain%20and%20Other%20Central%20Nervous%20System%20Tumors%20Diagnosed%20in%20the%20United%20States%20in%202016%E2%80%942020&amp;author=QT%20Ostrom&amp;author=M%20Price&amp;author=C%20Neff&amp;author=G%20Cioffi&amp;author=KA%20Waite&amp;volume=25&amp;issue=Supplement_4&amp;publication_year=2023&amp;pages=iv1-iv99&amp;pmid=37793125&amp;doi=10.1093/neuonc/noad149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. 
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987â€“96.
</cite> [<a href="https://doi.org/10.1056/NEJMoa043330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15758009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide%20for%20glioblastoma&amp;author=R%20Stupp&amp;author=WP%20Mason&amp;author=MJ%20van%20den%20Bent&amp;author=M%20Weller&amp;author=B%20Fisher&amp;volume=352&amp;issue=10&amp;publication_year=2005&amp;pages=987-96&amp;pmid=15758009&amp;doi=10.1056/NEJMoa043330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Dubrow R, and Darefsky AS. Demographic variation in incidence of adult glioma by subtype, United States, 1992â€“2007. BMC cancer. 2011;11:1â€“10.
</cite> [<a href="https://doi.org/10.1186/1471-2407-11-325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21801393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20cancer&amp;title=Demographic%20variation%20in%20incidence%20of%20adult%20glioma%20by%20subtype,%20United%20States,%201992%E2%80%932007&amp;author=R%20Dubrow&amp;author=AS%20Darefsky&amp;volume=11&amp;publication_year=2011&amp;pages=1-10&amp;pmid=21801393&amp;doi=10.1186/1471-2407-11-325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Holland EC. Glioblastoma multiforme: the terminator. Proceedings of the National Academy of Sciences. 2000;97(12):6242â€“4.</cite> [<a href="https://doi.org/10.1073/pnas.97.12.6242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC33993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10841526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences&amp;title=Glioblastoma%20multiforme:%20the%20terminator&amp;author=EC%20Holland&amp;volume=97&amp;issue=12&amp;publication_year=2000&amp;pages=6242-4&amp;pmid=10841526&amp;doi=10.1073/pnas.97.12.6242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. 
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal transduction and targeted therapy. 2021;6(1):1â€“48.
</cite> [<a href="https://doi.org/10.1038/s41392-021-00572-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8165101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34054126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20transduction%20and%20targeted%20therapy&amp;title=Small%20molecules%20in%20targeted%20cancer%20therapy:%20advances,%20challenges,%20and%20future%20perspectives&amp;author=L%20Zhong&amp;author=Y%20Li&amp;author=L%20Xiong&amp;author=W%20Wang&amp;author=M%20Wu&amp;volume=6&amp;issue=1&amp;publication_year=2021&amp;pages=1-48&amp;pmid=34054126&amp;doi=10.1038/s41392-021-00572-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, et al. 
A randomized trial of bevacizumab for newly diagnosed glioblastoma. New England Journal of Medicine. 2014;370(8):699â€“708.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1308573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4201043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24552317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=A%20randomized%20trial%20of%20bevacizumab%20for%20newly%20diagnosed%20glioblastoma&amp;author=MR%20Gilbert&amp;author=JJ%20Dignam&amp;author=TS%20Armstrong&amp;author=JS%20Wefel&amp;author=DT%20Blumenthal&amp;volume=370&amp;issue=8&amp;publication_year=2014&amp;pages=699-708&amp;pmid=24552317&amp;doi=10.1056/NEJMoa1308573&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Jain KK. A critical overview of targeted therapies for glioblastoma. Frontiers in oncology. 2018;8:419.
</cite> [<a href="https://doi.org/10.3389/fonc.2018.00419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6196260/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30374421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20oncology&amp;title=A%20critical%20overview%20of%20targeted%20therapies%20for%20glioblastoma&amp;author=KK%20Jain&amp;volume=8&amp;publication_year=2018&amp;pages=419&amp;pmid=30374421&amp;doi=10.3389/fonc.2018.00419&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Malumbres M, and Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nature reviews cancer. 2001;1(3):222â€“31.
</cite> [<a href="https://doi.org/10.1038/35106065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11902577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20reviews%20cancer&amp;title=To%20cycle%20or%20not%20to%20cycle:%20a%20critical%20decision%20in%20cancer&amp;author=M%20Malumbres&amp;author=M%20Barbacid&amp;volume=1&amp;issue=3&amp;publication_year=2001&amp;pages=222-31&amp;pmid=11902577&amp;doi=10.1038/35106065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Sherr CJ, Beach D, and Shapiro GI. Targeting CDK4 and CDK6: from discovery to therapy. Cancer discovery. 2016;6(4):353â€“67.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-15-0894" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4821753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26658964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20discovery&amp;title=Targeting%20CDK4%20and%20CDK6:%20from%20discovery%20to%20therapy&amp;author=CJ%20Sherr&amp;author=D%20Beach&amp;author=GI%20Shapiro&amp;volume=6&amp;issue=4&amp;publication_year=2016&amp;pages=353-67&amp;pmid=26658964&amp;doi=10.1158/2159-8290.CD-15-0894&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Patnaik A, Rosen LS, Tolaney SM, Tolcher AW, Goldman JW, Gandhi L, et al. 
Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, nonâ€“small cell lung cancer, and other solid tumors. Cancer discovery. 2016;6(7):740â€“53.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-16-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27217383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20discovery&amp;title=Efficacy%20and%20safety%20of%20abemaciclib,%20an%20inhibitor%20of%20CDK4%20and%20CDK6,%20for%20patients%20with%20breast%20cancer,%20non%E2%80%93small%20cell%20lung%20cancer,%20and%20other%20solid%20tumors&amp;author=A%20Patnaik&amp;author=LS%20Rosen&amp;author=SM%20Tolaney&amp;author=AW%20Tolcher&amp;author=JW%20Goldman&amp;volume=6&amp;issue=7&amp;publication_year=2016&amp;pages=740-53&amp;pmid=27217383&amp;doi=10.1158/2159-8290.CD-16-0095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Schettini F, De Santo I, Rea CG, De Placido P, Formisano L, Giuliano M, et al. 
CDK 4/6 inhibitors as single agent in advanced solid tumors. Frontiers in oncology. 2018;8:608.
</cite> [<a href="https://doi.org/10.3389/fonc.2018.00608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6315195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30631751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20oncology&amp;title=CDK%204/6%20inhibitors%20as%20single%20agent%20in%20advanced%20solid%20tumors&amp;author=F%20Schettini&amp;author=I%20De%20Santo&amp;author=CG%20Rea&amp;author=P%20De%20Placido&amp;author=L%20Formisano&amp;volume=8&amp;publication_year=2018&amp;pages=608&amp;pmid=30631751&amp;doi=10.3389/fonc.2018.00608&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, et al. 
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. Journal of neuro-oncology. 2018;140:477â€“83.
</cite> [<a href="https://doi.org/10.1007/s11060-018-2977-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6239922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30151703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20neuro-oncology&amp;title=Phase-2%20trial%20of%20palbociclib%20in%20adult%20patients%20with%20recurrent%20RB1-positive%20glioblastoma&amp;author=JW%20Taylor&amp;author=M%20Parikh&amp;author=JJ%20Phillips&amp;author=CD%20James&amp;author=AM%20Molinaro&amp;volume=140&amp;publication_year=2018&amp;pages=477-83&amp;pmid=30151703&amp;doi=10.1007/s11060-018-2977-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Raub TJ, Wishart GN, Kulanthaivel P, Staton BA, Ajamie RT, Sawada GA, et al. 
Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft. Drug Metabolism and Disposition. 2015;43(9):1360â€“71.
</cite> [<a href="https://doi.org/10.1124/dmd.114.062745" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26149830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Metabolism%20and%20Disposition&amp;title=Brain%20exposure%20of%20two%20selective%20dual%20CDK4%20and%20CDK6%20inhibitors%20and%20the%20antitumor%20activity%20of%20CDK4%20and%20CDK6%20inhibition%20in%20combination%20with%20temozolomide%20in%20an%20intracranial%20glioblastoma%20xenograft&amp;author=TJ%20Raub&amp;author=GN%20Wishart&amp;author=P%20Kulanthaivel&amp;author=BA%20Staton&amp;author=RT%20Ajamie&amp;volume=43&amp;issue=9&amp;publication_year=2015&amp;pages=1360-71&amp;pmid=26149830&amp;doi=10.1124/dmd.114.062745&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Goel S, Bergholz JS, and Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nature Reviews Cancer. 2022;22(6):356â€“72.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00456-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9149100/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35304604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Cancer&amp;title=Targeting%20CDK4%20and%20CDK6%20in%20cancer&amp;author=S%20Goel&amp;author=JS%20Bergholz&amp;author=JJ%20Zhao&amp;volume=22&amp;issue=6&amp;publication_year=2022&amp;pages=356-72&amp;pmid=35304604&amp;doi=10.1038/s41568-022-00456-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, and Johnson MD. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proceedings of the National Academy of Sciences. 2010;107(5):2183â€“8.</cite> [<a href="https://doi.org/10.1073/pnas.0909896107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2836668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20080666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences&amp;title=Integrative%20genome%20analysis%20reveals%20an%20oncomir/oncogene%20cluster%20regulating%20glioblastoma%20survivorship&amp;author=H%20Kim&amp;author=W%20Huang&amp;author=X%20Jiang&amp;author=B%20Pennicooke&amp;author=PJ%20Park&amp;volume=107&amp;issue=5&amp;publication_year=2010&amp;pages=2183-8&amp;pmid=20080666&amp;doi=10.1073/pnas.0909896107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y, et al. 
miR-124 radiosensitizes human glioma cells by targeting CDK4. Journal of neuro-oncology. 2013;114:263â€“74.
</cite> [<a href="https://doi.org/10.1007/s11060-013-1179-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23761023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20neuro-oncology&amp;title=miR-124%20radiosensitizes%20human%20glioma%20cells%20by%20targeting%20CDK4&amp;author=X%20Deng&amp;author=L%20Ma&amp;author=M%20Wu&amp;author=G%20Zhang&amp;author=C%20Jin&amp;volume=114&amp;publication_year=2013&amp;pages=263-74&amp;pmid=23761023&amp;doi=10.1007/s11060-013-1179-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>LÃ³pez GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, et al. 
The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathologica. 2019;137:139â€“50.
</cite> [<a href="https://doi.org/10.1007/s00401-018-1906-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6589431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30196423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathologica&amp;title=The%20genetic%20landscape%20of%20gliomas%20arising%20after%20therapeutic%20radiation&amp;author=GY%20L%C3%B3pez&amp;author=J%20Van%20Ziffle&amp;author=C%20Onodera&amp;author=JP%20Grenert&amp;author=I%20Yeh&amp;volume=137&amp;publication_year=2019&amp;pages=139-50&amp;pmid=30196423&amp;doi=10.1007/s00401-018-1906-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Dai Z, Wang L, Wang X, Zhao B, Zhao W, Bhardwaj SS, et al. 
Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling pathway and STAT3. Oncology reports. 2018;40(2):867â€“76.
</cite> [<a href="https://doi.org/10.3892/or.2018.6512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29989652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20reports&amp;title=Oxymatrine%20induces%20cell%20cycle%20arrest%20and%20apoptosis%20and%20suppresses%20the%20invasion%20of%20human%20glioblastoma%20cells%20through%20the%20EGFR/PI3K/Akt/mTOR%20signaling%20pathway%20and%20STAT3&amp;author=Z%20Dai&amp;author=L%20Wang&amp;author=X%20Wang&amp;author=B%20Zhao&amp;author=W%20Zhao&amp;volume=40&amp;issue=2&amp;publication_year=2018&amp;pages=867-76&amp;pmid=29989652&amp;doi=10.3892/or.2018.6512&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Michaud K, Solomon DA, Oermann E, Kim J-S, Zhong W-Z, Prados MD, et al. 
Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. Cancer research. 2010;70(8):3228â€“38.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-4559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2855904/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20354191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20research&amp;title=Pharmacologic%20inhibition%20of%20cyclin-dependent%20kinases%204%20and%206%20arrests%20the%20growth%20of%20glioblastoma%20multiforme%20intracranial%20xenografts&amp;author=K%20Michaud&amp;author=DA%20Solomon&amp;author=E%20Oermann&amp;author=J-S%20Kim&amp;author=W-Z%20Zhong&amp;volume=70&amp;issue=8&amp;publication_year=2010&amp;pages=3228-38&amp;pmid=20354191&amp;doi=10.1158/0008-5472.CAN-09-4559&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Benefit OS. CTNI-47. Phase II study of abemaciclib in recurrent GBM patients with CDKN2A/B loss and intact RB. Neuro-oncology. 2020.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro-oncology&amp;title=CTNI-47.%20Phase%20II%20study%20of%20abemaciclib%20in%20recurrent%20GBM%20patients%20with%20CDKN2A/B%20loss%20and%20intact%20RB&amp;author=OS%20Benefit&amp;publication_year=2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Wen P, Trippa L, Lee E, Fell G, Rahman R, Arrillaga-Romany I, et al. 
CTNI-12. Preliminary results of the abemaciclib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGHT): a phase II platform trial using Bayesian adaptive randomization. Neuro-oncology. 2020;22(Supplement_2):ii44.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro-oncology&amp;title=CTNI-12.%20Preliminary%20results%20of%20the%20abemaciclib%20arm%20in%20the%20individualized%20screening%20trial%20of%20innovative%20glioblastoma%20therapy%20(INSIGHT):%20a%20phase%20II%20platform%20trial%20using%20Bayesian%20adaptive%20randomization&amp;author=P%20Wen&amp;author=L%20Trippa&amp;author=E%20Lee&amp;author=G%20Fell&amp;author=R%20Rahman&amp;volume=22&amp;issue=Supplement_2&amp;publication_year=2020&amp;pages=ii44&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Lo H-W, Zhu H, Cao X, Aldrich A, and Ali-Osman F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer research. 2009;69(17):6790â€“8.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-0886" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2771365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19706761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20research&amp;title=A%20novel%20splice%20variant%20of%20GLI1%20that%20promotes%20glioblastoma%20cell%20migration%20and%20invasion&amp;author=H-W%20Lo&amp;author=H%20Zhu&amp;author=X%20Cao&amp;author=A%20Aldrich&amp;author=F%20Ali-Osman&amp;volume=69&amp;issue=17&amp;publication_year=2009&amp;pages=6790-8&amp;pmid=19706761&amp;doi=10.1158/0008-5472.CAN-09-0886&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Cao X, Geradts J, Dewhirst MW, and Lo H-W. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene. 2012;31(1):104â€“15.
</cite> [<a href="https://doi.org/10.1038/onc.2011.219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3175334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21666711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Upregulation%20of%20VEGF-A%20and%20CD24%20gene%20expression%20by%20the%20tGLI1%20transcription%20factor%20contributes%20to%20the%20aggressive%20behavior%20of%20breast%20cancer%20cells&amp;author=X%20Cao&amp;author=J%20Geradts&amp;author=MW%20Dewhirst&amp;author=H-W%20Lo&amp;volume=31&amp;issue=1&amp;publication_year=2012&amp;pages=104-15&amp;pmid=21666711&amp;doi=10.1038/onc.2011.219&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Sirkisoon SR, Carpenter RL, Rimkus T, Anderson A, Harrison A, Lange AM, et al. 
Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene. 2018;37(19):2502â€“14.
</cite> [<a href="https://doi.org/10.1038/s41388-018-0132-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5948110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29449694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Interaction%20between%20STAT3%20and%20GLI1/tGLI1%20oncogenic%20transcription%20factors%20promotes%20the%20aggressiveness%20of%20triple-negative%20breast%20cancers%20and%20HER2-enriched%20breast%20cancer&amp;author=SR%20Sirkisoon&amp;author=RL%20Carpenter&amp;author=T%20Rimkus&amp;author=A%20Anderson&amp;author=A%20Harrison&amp;volume=37&amp;issue=19&amp;publication_year=2018&amp;pages=2502-14&amp;pmid=29449694&amp;doi=10.1038/s41388-018-0132-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Carpenter RL, Paw I, Zhu H, Sirkisoon S, Xing F, Watabe K, et al. 
The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Oncotarget. 2015;6(26):22653.
</cite> [<a href="https://doi.org/10.18632/oncotarget.4248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4673189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26093087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=The%20gain-of-function%20GLI1%20transcription%20factor%20TGLI1%20enhances%20expression%20of%20VEGF-C%20and%20TEM7%20to%20promote%20glioblastoma%20angiogenesis&amp;author=RL%20Carpenter&amp;author=I%20Paw&amp;author=H%20Zhu&amp;author=S%20Sirkisoon&amp;author=F%20Xing&amp;volume=6&amp;issue=26&amp;publication_year=2015&amp;pages=22653&amp;pmid=26093087&amp;doi=10.18632/oncotarget.4248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Rimkus TK, Carpenter RL, Sirkisoon S, Zhu D, Pasche BC, Chan MD, et al. 
Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44. Cancer research. 2018;78(10):2589â€“600.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-17-2933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5955849/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29463580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20research&amp;title=Truncated%20glioma-associated%20oncogene%20homolog%201%20(tGLI1)%20mediates%20mesenchymal%20glioblastoma%20via%20transcriptional%20activation%20of%20CD44&amp;author=TK%20Rimkus&amp;author=RL%20Carpenter&amp;author=S%20Sirkisoon&amp;author=D%20Zhu&amp;author=BC%20Pasche&amp;volume=78&amp;issue=10&amp;publication_year=2018&amp;pages=2589-600&amp;pmid=29463580&amp;doi=10.1158/0008-5472.CAN-17-2933&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Zhu H, Carpenter RL, Han W, and Lo H-W. The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth. Cancer letters. 2014;343(1):51â€“61.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2013.09.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3874262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24045042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20letters&amp;title=The%20GLI1%20splice%20variant%20TGLI1%20promotes%20glioblastoma%20angiogenesis%20and%20growth&amp;author=H%20Zhu&amp;author=RL%20Carpenter&amp;author=W%20Han&amp;author=H-W%20Lo&amp;volume=343&amp;issue=1&amp;publication_year=2014&amp;pages=51-61&amp;pmid=24045042&amp;doi=10.1016/j.canlet.2013.09.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Doheny D, Manore S, Sirkisoon SR, Zhu D, Aguayo NR, Harrison A, et al. 
An FDA-approved antifungal, ketoconazole, and its novel derivative suppress tGLI1-mediated breast cancer brain metastasis by inhibiting the DNA-binding activity of brain metastasis-promoting transcription factor tGLI1. Cancers. 2022;14(17):4256.
</cite> [<a href="https://doi.org/10.3390/cancers14174256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9454738/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36077791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=An%20FDA-approved%20antifungal,%20ketoconazole,%20and%20its%20novel%20derivative%20suppress%20tGLI1-mediated%20breast%20cancer%20brain%20metastasis%20by%20inhibiting%20the%20DNA-binding%20activity%20of%20brain%20metastasis-promoting%20transcription%20factor%20tGLI1&amp;author=D%20Doheny&amp;author=S%20Manore&amp;author=SR%20Sirkisoon&amp;author=D%20Zhu&amp;author=NR%20Aguayo&amp;volume=14&amp;issue=17&amp;publication_year=2022&amp;pages=4256&amp;pmid=36077791&amp;doi=10.3390/cancers14174256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Eckerdt F, and Platanias LC. Emerging role of glioma stem cells in mechanisms of therapy resistance. Cancers. 2023;15(13):3458.
</cite> [<a href="https://doi.org/10.3390/cancers15133458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10340782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37444568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Emerging%20role%20of%20glioma%20stem%20cells%20in%20mechanisms%20of%20therapy%20resistance&amp;author=F%20Eckerdt&amp;author=LC%20Platanias&amp;volume=15&amp;issue=13&amp;publication_year=2023&amp;pages=3458&amp;pmid=37444568&amp;doi=10.3390/cancers15133458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. 
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery. 2012;2(5):401â€“4.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-12-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3956037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22588877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20discovery&amp;title=The%20cBio%20cancer%20genomics%20portal:%20an%20open%20platform%20for%20exploring%20multidimensional%20cancer%20genomics%20data&amp;author=E%20Cerami&amp;author=J%20Gao&amp;author=U%20Dogrusoz&amp;author=BE%20Gross&amp;author=SO%20Sumer&amp;volume=2&amp;issue=5&amp;publication_year=2012&amp;pages=401-4&amp;pmid=22588877&amp;doi=10.1158/2159-8290.CD-12-0095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. 
Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer research. 2023;83(23):3861â€“7.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-23-0816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10690089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37668528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20research&amp;title=Analysis%20and%20visualization%20of%20longitudinal%20genomic%20and%20clinical%20data%20from%20the%20AACR%20project%20GENIE%20biopharma%20collaborative%20in%20cBioPortal&amp;author=I%20de%20Bruijn&amp;author=R%20Kundra&amp;author=B%20Mastrogiacomo&amp;author=TN%20Tran&amp;author=L%20Sikina&amp;volume=83&amp;issue=23&amp;publication_year=2023&amp;pages=3861-7&amp;pmid=37668528&amp;doi=10.1158/0008-5472.CAN-23-0816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. 
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling. 2013;6(269):pl1.
</cite> [<a href="https://doi.org/10.1126/scisignal.2004088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4160307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23550210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20signaling&amp;title=Integrative%20analysis%20of%20complex%20cancer%20genomics%20and%20clinical%20profiles%20using%20the%20cBioPortal&amp;author=J%20Gao&amp;author=BA%20Aksoy&amp;author=U%20Dogrusoz&amp;author=G%20Dresdner&amp;author=B%20Gross&amp;volume=6&amp;issue=269&amp;publication_year=2013&amp;pages=pl1&amp;pmid=23550210&amp;doi=10.1126/scisignal.2004088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Auffinger B, Spencer D, Pytel P, Ahmed AU, and Lesniak MS. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother. 2015;15(7):741â€“52.
</cite> [<a href="https://doi.org/10.1586/14737175.2015.1051968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4830899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26027432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Neurother&amp;title=The%20role%20of%20glioma%20stem%20cells%20in%20chemotherapy%20resistance%20and%20glioblastoma%20multiforme%20recurrence&amp;author=B%20Auffinger&amp;author=D%20Spencer&amp;author=P%20Pytel&amp;author=AU%20Ahmed&amp;author=MS%20Lesniak&amp;volume=15&amp;issue=7&amp;publication_year=2015&amp;pages=741-52&amp;pmid=26027432&amp;doi=10.1586/14737175.2015.1051968&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Chandra A, Jahangiri A, Chen W, Nguyen AT, Yagnik G, Pereira MP, et al. 
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance. Cancer Res. 2020;80(7):1498â€“511.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-19-1305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7236890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32041837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Clonal%20ZEB1-Driven%20Mesenchymal%20Transition%20Promotes%20Targetable%20Oncologic%20Antiangiogenic%20Therapy%20Resistance&amp;author=A%20Chandra&amp;author=A%20Jahangiri&amp;author=W%20Chen&amp;author=AT%20Nguyen&amp;author=G%20Yagnik&amp;volume=80&amp;issue=7&amp;publication_year=2020&amp;pages=1498-511&amp;pmid=32041837&amp;doi=10.1158/0008-5472.CAN-19-1305&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Pandey K, An HJ, Kim SK, Lee SA, Kim S, Lim SM, et al. 
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review. International journal of cancer. 2019;145(5):1179â€“88.
</cite> [<a href="https://doi.org/10.1002/ijc.32020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6767051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30478914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20journal%20of%20cancer&amp;title=Molecular%20mechanisms%20of%20resistance%20to%20CDK4/6%20inhibitors%20in%20breast%20cancer:%20A%20review&amp;author=K%20Pandey&amp;author=HJ%20An&amp;author=SK%20Kim&amp;author=SA%20Lee&amp;author=S%20Kim&amp;volume=145&amp;issue=5&amp;publication_year=2019&amp;pages=1179-88&amp;pmid=30478914&amp;doi=10.1002/ijc.32020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Chou T-C, and Talalay P.
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation. 1984;22:27â€“55.
</cite> [<a href="https://doi.org/10.1016/0065-2571(84)90007-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6382953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Enzyme%20Regulation&amp;title=Quantitative%20analysis%20of%20dose-effect%20relationships:%20the%20combined%20effects%20of%20multiple%20drugs%20or%20enzyme%20inhibitors&amp;author=T-C%20Chou&amp;author=P.%20Talalay&amp;volume=22&amp;publication_year=1984&amp;pages=27-55&amp;pmid=6382953&amp;doi=10.1016/0065-2571(84)90007-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Liu X, Chen H, and Patel DJ. Solution structure of actinomycin-DNA complexes: drug intercalation at isolated GC sites. Journal of Biomolecular NMR. 1991;1:323â€“47.
</cite> [<a href="https://doi.org/10.1007/BF02192858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1841703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biomolecular%20NMR&amp;title=Solution%20structure%20of%20actinomycin-DNA%20complexes:%20drug%20intercalation%20at%20isolated%20GC%20sites&amp;author=X%20Liu&amp;author=H%20Chen&amp;author=DJ%20Patel&amp;volume=1&amp;publication_year=1991&amp;pages=323-47&amp;pmid=1841703&amp;doi=10.1007/BF02192858&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Pucci B, Kasten M, and Giordano A. Cell cycle and apoptosis. Neoplasia. 2000;2(4):291â€“9.
</cite> [<a href="https://doi.org/10.1038/sj.neo.7900101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1550296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11005563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Cell%20cycle%20and%20apoptosis&amp;author=B%20Pucci&amp;author=M%20Kasten&amp;author=A%20Giordano&amp;volume=2&amp;issue=4&amp;publication_year=2000&amp;pages=291-9&amp;pmid=11005563&amp;doi=10.1038/sj.neo.7900101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, et al. 
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions. PloS one. 2023;18(2):e0281166.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0281166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9894455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36730349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PloS%20one&amp;title=Survival%20in%20a%20consecutive%20series%20of%20467%20glioblastoma%20patients:%20Association%20with%20prognostic%20factors%20and%20treatment%20at%20recurrence%20at%20two%20independent%20institutions&amp;author=H%20Blakstad&amp;author=J%20Brekke&amp;author=MA%20Rahman&amp;author=VS%20Arnesen&amp;author=H%20Miletic&amp;volume=18&amp;issue=2&amp;publication_year=2023&amp;pages=e0281166&amp;pmid=36730349&amp;doi=10.1371/journal.pone.0281166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Sundar SJ, Hsieh JK, Manjila S, Lathia JD, and Sloan A. The role of cancer stem cells in glioblastoma. Neurosurgical focus. 2014;37(6):E6.</cite> [<a href="https://doi.org/10.3171/2014.9.FOCUS14494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25434391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosurgical%20focus&amp;title=The%20role%20of%20cancer%20stem%20cells%20in%20glioblastoma&amp;author=SJ%20Sundar&amp;author=JK%20Hsieh&amp;author=S%20Manjila&amp;author=JD%20Lathia&amp;author=A%20Sloan&amp;volume=37&amp;issue=6&amp;publication_year=2014&amp;pages=E6&amp;pmid=25434391&amp;doi=10.3171/2014.9.FOCUS14494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Cicenas J, and Simkus J. CDK Inhibitors and FDA: Approved and Orphan. Cancers (Basel). 2024;16(8).</cite> [<a href="https://doi.org/10.3390/cancers16081555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11049492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38672637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=CDK%20Inhibitors%20and%20FDA:%20Approved%20and%20Orphan&amp;author=J%20Cicenas&amp;author=J%20Simkus&amp;volume=16&amp;issue=8&amp;publication_year=2024&amp;pmid=38672637&amp;doi=10.3390/cancers16081555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Carpenter RL, Paw I, Dewhirst MW, and Lo H-W. Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelialâ€“mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells. Oncogene. 2015;34(5):546â€“57.
</cite> [<a href="https://doi.org/10.1038/onc.2013.582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4112182/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24469056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Akt%20phosphorylates%20and%20activates%20HSF-1%20independent%20of%20heat%20shock,%20leading%20to%20Slug%20overexpression%20and%20epithelial%E2%80%93mesenchymal%20transition%20(EMT)%20of%20HER2-overexpressing%20breast%20cancer%20cells&amp;author=RL%20Carpenter&amp;author=I%20Paw&amp;author=MW%20Dewhirst&amp;author=H-W%20Lo&amp;volume=34&amp;issue=5&amp;publication_year=2015&amp;pages=546-57&amp;pmid=24469056&amp;doi=10.1038/onc.2013.582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>Laroche-Clary A, Chaire V, Algeo M-P, Derieppe M-A, Loarer FL, and Italiano A. Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas. Journal of hematology &amp; oncology. 2017;10:1â€“10.
</cite> [<a href="https://doi.org/10.1186/s13045-017-0482-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5477309/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28629371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20hematology%20&amp;%20oncology&amp;title=Combined%20targeting%20of%20MDM2%20and%20CDK4%20is%20synergistic%20in%20dedifferentiated%20liposarcomas&amp;author=A%20Laroche-Clary&amp;author=V%20Chaire&amp;author=M-P%20Algeo&amp;author=M-A%20Derieppe&amp;author=FL%20Loarer&amp;volume=10&amp;publication_year=2017&amp;pages=1-10&amp;pmid=28629371&amp;doi=10.1186/s13045-017-0482-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R45">
<span class="label">45.</span><cite>Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, et al. 
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer. Clinical Cancer Research. 2019;25(13):3996â€“4013.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-18-3274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6606366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30867218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=Combined%20inhibition%20of%20STAT3%20and%20DNA%20repair%20in%20palbociclib-resistant%20ER-positive%20breast%20cancer&amp;author=NM%20Kettner&amp;author=S%20Vijayaraghavan&amp;author=MG%20Durak&amp;author=T%20Bui&amp;author=M%20Kohansal&amp;volume=25&amp;issue=13&amp;publication_year=2019&amp;pages=3996-4013&amp;pmid=30867218&amp;doi=10.1158/1078-0432.CCR-18-3274&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R46">
<span class="label">46.</span><cite>Shi J, Lv S, Wu M, Wang X, Deng Y, Li Y, et al. 
HOTAIR-EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma. Clinical and Translational Medicine. 2020;10(1):182â€“98.
</cite> [<a href="https://doi.org/10.1002/ctm2.21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7240863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32508030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Translational%20Medicine&amp;title=HOTAIR-EZH2%20inhibitor%20AC1Q3QWB%20upregulates%20CWF19L1%20and%20enhances%20cell%20cycle%20inhibition%20of%20CDK4/6%20inhibitor%20palbociclib%20in%20glioma&amp;author=J%20Shi&amp;author=S%20Lv&amp;author=M%20Wu&amp;author=X%20Wang&amp;author=Y%20Deng&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=182-98&amp;pmid=32508030&amp;doi=10.1002/ctm2.21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Olmez I, Brenneman B, Xiao A, Serbulea V, Benamar M, Zhang Y, et al. 
Combined CDK4/6 and mTOR inhibition is synergistic against glioblastoma via multiple mechanisms. Clinical Cancer Research. 2017;23(22):6958â€“68.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-17-0803" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5690820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28814434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=Combined%20CDK4/6%20and%20mTOR%20inhibition%20is%20synergistic%20against%20glioblastoma%20via%20multiple%20mechanisms&amp;author=I%20Olmez&amp;author=B%20Brenneman&amp;author=A%20Xiao&amp;author=V%20Serbulea&amp;author=M%20Benamar&amp;volume=23&amp;issue=22&amp;publication_year=2017&amp;pages=6958-68&amp;pmid=28814434&amp;doi=10.1158/1078-0432.CCR-17-0803&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Cretella D, Ravelli A, Fumarola C, La Monica S, Digiacomo G, Cavazzoni A, et al. 
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells. Journal of Experimental &amp; Clinical Cancer Research. 2018;37:1â€“12.
</cite> [<a href="https://doi.org/10.1186/s13046-018-0741-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5872523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29587820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20&amp;%20Clinical%20Cancer%20Research&amp;title=The%20anti-tumor%20efficacy%20of%20CDK4/6%20inhibition%20is%20enhanced%20by%20the%20combination%20with%20PI3K/AKT/mTOR%20inhibitors%20through%20impairment%20of%20glucose%20metabolism%20in%20TNBC%20cells&amp;author=D%20Cretella&amp;author=A%20Ravelli&amp;author=C%20Fumarola&amp;author=S%20La%20Monica&amp;author=G%20Digiacomo&amp;volume=37&amp;publication_year=2018&amp;pages=1-12&amp;pmid=29587820&amp;doi=10.1186/s13046-018-0741-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R49">
<span class="label">49.</span><cite>Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, et al. 
CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017;548(7668):471â€“5.
</cite> [<a href="https://doi.org/10.1038/nature23465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5570667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28813415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=CDK4/6%20inhibition%20triggers%20anti-tumour%20immunity&amp;author=S%20Goel&amp;author=MJ%20DeCristo&amp;author=AC%20Watt&amp;author=H%20BrinJones&amp;author=J%20Sceneay&amp;volume=548&amp;issue=7668&amp;publication_year=2017&amp;pages=471-5&amp;pmid=28813415&amp;doi=10.1038/nature23465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R50">
<span class="label">50.</span><cite>Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, Singh M, Torrini C, et al. 
CDK4/6 inhibition sensitizes intracranial tumors to PD-1 blockade in preclinical models of brain metastasis. Clinical Cancer Research. 2024;30(2):420â€“35.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-23-0433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10872577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37611074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=CDK4/6%20inhibition%20sensitizes%20intracranial%20tumors%20to%20PD-1%20blockade%20in%20preclinical%20models%20of%20brain%20metastasis&amp;author=N%20Nayyar&amp;author=MA%20de%20Sauvage&amp;author=J%20Chuprin&amp;author=EM%20Sullivan&amp;author=M%20Singh&amp;volume=30&amp;issue=2&amp;publication_year=2024&amp;pages=420-35&amp;pmid=37611074&amp;doi=10.1158/1078-0432.CCR-23-0433&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplement 1</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11888219/bin/media-1.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-1.pdf</a><sup> (150.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>Supplement 2</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11888219/bin/media-2.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-2.pdf</a><sup> (518.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><span>Supplement 3</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11888219/bin/media-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">media-3.pdf</a><sup> (1.4MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from bioRxiv are provided here courtesy of <strong>Cold Spring Harbor Laboratory Preprints</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1101/2025.02.20.639359"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/nihpp-2025.02.20.639359v1.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11888219/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11888219/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11888219%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11888219/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11888219/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11888219/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40060625/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11888219/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40060625/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11888219/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11888219/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="VzBESinVgIDpNYhN2SM1JTeslLXJcXzwBLMSsGCR3tqILTiE2pIIVkayxN1TsabO">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
